ANDRIANANTOANDRO E , BASU S , KARIG D K , et al . Synthetic biology: new engineering rules for an emerging discipline [J ] . Molecular Systems Biology , 2006 , 2 : 2006 .0028.

BRENNER K , YOU L C , ARNOLD F H . Engineering microbial consortia: a new frontier in synthetic biology [J ] . Trends in Biotechnology , 2008 , 26 ( 9 ): 483 - 489 .

JAROENTOMEECHAI T , TAW M N , LI M J , et al . Cell-free synthetic glycobiology: designing and engineering glycomolecules outside of living cells [J ] . Frontiers in Chemistry , 2020 , 8 : 645 .

KHOURY G A , BALIBAN R C , FLOUDAS C A . Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database [J ] . Scientific Reports , 2011 , 1 : 90 .

HELENIUS A , AEBI A M . Intracellular functions of N -linked glycans [J ] . Science , 2001 , 291 ( 5512 ): 2364 - 2369 .

RUDD P M , WORMALD M R , STANFIELD R L , et al . Roles for glycosylation of cell surface receptors involved in cellular immune recognition [J ] . Journal of Molecular Biology , 1999 , 293 ( 2 ): 351 - 366 .

TYTGAT H L P , LEBEER S . The sweet tooth of bacteria: common themes in bacterial glycoconjugates [J ] . Microbiology and Molecular Biology Reviews: MMBR , 2014 , 78 ( 3 ): 372 - 417 .

STRENG-OUWEHAND I , HO N I , LITJENS M , et al . Glycan modification of antigen alters its intracellular routing in dendritic cells, promoting priming of T cells [J ] . eLife , 2016 , 5 : e11765 .

PHANSE Y , CARRILLO-CONDE B R , RAMER-TAIT A E , et al . A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms [J ] . Scientific Reports , 2014 , 4 : 3775 .

ELLIOTT S , LORENZINI T , ASHER S , et al . Enhancement of therapeutic protein in vivo activities through glycoengineering [J ] . Nature Biotechnology , 2003 , 21 ( 4 ): 414 - 421 .

OHTSUBO K , MARTH J D . Glycosylation in cellular mechanisms of health and disease [J ] . Cell , 2006 , 126 ( 5 ): 855 - 867 .

ZHANG Q , JOHNSTON E V , SHIEH J H , et al . Synthesis of granulocyte-macrophage colony-stimulating factor as homogeneous glycoforms and early comparisons with yeast cell-derived material [J ] . Proceedings of the National Academy of Sciences of the United States of America , 2014 , 111 ( 8 ): 2885 - 2890 .

CHUNG C H , MIRAKHUR B , CHAN E , et al . Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose [J ] . New England Journal of Medicine , 2008 , 358 ( 11 ): 1109 - 1117 .

LI H J , SETHURAMAN N , STADHEIM T A , et al . Optimization of humanized IgGs in glycoengineered Pichia pastoris [J ] . Nature Biotechnology , 2006 , 24 ( 2 ): 210 - 215 .

TIAN W H , YE Z L , WANG S J , et al . The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells [J ] . Nature Communications , 2019 , 10 : 1785 .

ABREU A G , BARBOSA A S . How Escherichia coli circumvent complement-mediated killing [J ] . Frontiers in Immunology , 2017 , 8 : 452 .

BUNDLE D . Antibacterials: a sweet vaccine [J ] . Nature Chemistry , 2016 , 8 ( 3 ): 201 - 202 .

SZYMANSKI C M , YAO R J , EWING C P , et al . Evidence for a system of general protein glycosylation in Campylobacter jejuni [J ] . Molecular Microbiology , 1999 , 32 ( 5 ): 1022 - 1030 .

PARKHILL J , WREN B W , MUNGALL K , et al . The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences [J ] . Nature , 2000 , 403 ( 6770 ): 665 - 668 .

FELDMAN M F , WACKER M , HERNANDEZ M , et al . Engineering N -linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli [J ] . Proceedings of the National Academy of Sciences of the United States of America , 2005 , 102 ( 8 ): 3016 - 3021 .

BERTANI B , RUIZ N . Function and biogenesis of lipopolysaccharides [J ] . EcoSal Plus , 2018 , 8 ( 1 ): ESP-0001-2018 .

WHITFIELD C , WEAR S S , SANDE C . Assembly of bacterial capsular polysaccharides and exopolysaccharides [J ] . Annual Review of Microbiology , 2020 , 74 : 521 - 543 .

KOWARIK M , YOUNG N M , NUMAO S , et al . Definition of the bacterial N -glycosylation site consensus sequence [J ] . The EMBO Journal , 2006 , 25 ( 9 ): 1957 - 1966 .

IHSSEN J , KOWARIK M , DILETTOSO S , et al . Production of glycoprotein vaccines in Escherichia coli [J ] . Microbial Cell Factories , 2010 , 9 : 61 .

HATZ C F R , BALLY B , ROHRER S , et al . Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: a single blind, partially randomized Phase Ⅰ study [J ] . Vaccine , 2015 , 33 ( 36 ): 4594 - 4601 .

RAVENSCROFT N , BRAUN M , SCHNEIDER J , et al . Characterization and immunogenicity of a Shigella flexneri 2a O -antigen bioconjugate vaccine candidate [J ] . Glycobiology , 2019 , 29 ( 9 ): 669 - 680 .

VAN DEN DOBBELSTEEN G P J M , FAÉ K C , SERROYEN J , et al . Immunogenicity and safety of a tetravalent E. coli O -antigen bioconjugate vaccine in animal models [J ] . Vaccine , 2016 , 34 ( 35 ): 4152 - 4160 .

MARSHALL L E , NELSON M , DAVIES C H , et al . An O -antigen glycoconjugate vaccine produced using protein glycan coupling technology is protective in an inhalational rat model of tularemia [J ] . Journal of Immunology Research , 2018 , 2018 : 8087916 .

GARCIA-QUINTANILLA F , IWASHKIW J A , PRICE N L , et al . Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N -glycosylation machinery [J ] . Frontiers in Microbiology , 2014 , 5 : 381 .

IWASHKIW J A , FENTABIL M A , FARIDMOAYER A , et al . Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis [J ] . Microbial Cell Factories , 2012 , 11 : 13 .

WACKER M , WANG L H , KOWARIK M , et al . Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli [J ] . The Journal of Infectious Diseases , 2014 , 209 ( 10 ): 1551 - 1561 .

HERBERT J A , KAY E J , FAUSTINI S E , et al . Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine [J ] . Vaccine , 2018 , 36 ( 26 ): 3809 - 3819 .

LIZAK C , GERBER S , NUMAO S , et al . X-ray structure of a bacterial oligosaccharyltransferase [J ] . Nature , 2011 , 474 ( 7351 ): 350 - 355 .

NAPIÓRKOWSKA M , BOILEVIN J , SOVDAT T , et al . Molecular basis of lipid-linked oligosaccharide recognition and processing by bacterial oligosaccharyltransferase [J ] . Nature Structural & Molecular Biology , 2017 , 24 ( 12 ): 1100 - 1106 .

IHSSEN J , HAAS J , KOWARIK M , et al . Increased efficiency of Campylobacter jejuni N -oligosaccharyltransferase PglB by structure-guided engineering [J ] . Open Biology , 2015 , 5 ( 4 ): 140227 .

STIMSON E , VIRJI M , BARKER S , et al . Discovery of a novel protein modification: α-glycerophosphate is a substituent of meningococcal pilin [J ] . Biochemical Journal , 1996 , 316 ( 1 ): 29 - 33 .

FARIDMOAYER A , FENTABIL M A , MILLS D C , et al . Functional characterization of bacterial oligosaccharyltransferases involved in O -linked protein glycosylation [J ] . Journal of Bacteriology , 2007 , 189 ( 22 ): 8088 - 8098 .

FARIDMOAYER A , FENTABIL M A , HAURAT M F , et al . Extreme substrate promiscuity of the Neisseria oligosaccharyl transferase involved in protein O -glycosylation [J ] . Journal of Biological Chemistry , 2008 , 283 ( 50 ): 34596 - 34604 .

PAN C , SUN P , LIU B , et al . Biosynthesis of conjugate vaccines using an O -linked glycosylation system [J ] . mBio , 2016 , 7 ( 2 ): e00443-16 .

SUN P , PAN C , ZENG M , et al . Design and production of conjugate vaccines against S. Paratyphi A using an O -linked glycosylation system in vivo [J ] . NPJ Vaccines , 2018 , 3 : 4 .

LI S L , HUANG J , WANG K F , et al . A bioconjugate vaccine against Brucella abortus produced by engineered Escherichia coli [J ] . Frontiers in Bioengineering and Biotechnology , 2023 , 11 : 1121074 .

LIU Y , PAN C , WANG K F , et al . Preparation of a Klebsiella pneumoniae conjugate nanovaccine using glycol-engineered Escherichia coli [J ] . Microbial Cell Factories , 2023 , 22 ( 1 ): 95 .

SCHULZ B L , JEN F E C , POWER P M , et al . Identification of bacterial protein O -oligosaccharyltransferases and their glycoprotein substrates [J ] . PLoS One , 2013 , 8 ( 5 ): e62768 .

GEBHART C , IELMINI M V , REIZ B , et al . Characterization of exogenous bacterial oligosaccharyltransferases in Escherichia coli reveals the potential for O -linked protein glycosylation in Vibrio cholerae and Burkholderia thailandensis [J ] . Glycobiology , 2012 , 22 ( 7 ): 962 - 974 .

ELHENAWY W , SCOTT N E , TONDO M L , et al . Protein O -linked glycosylation in the plant pathogen Ralstonia solanacearum [J ] . Glycobiology , 2016 , 26 ( 3 ): 301 - 311 .

HADJINEOPHYTOU C , ANONSEN J H , SVINGERUD T , et al . Sculpting the bacterial O -glycoproteome: functional analyses of orthologous oligosaccharyltransferases with diverse targeting specificities [J ] . mBio , 2022 , 13 ( 3 ): e0379721 .

HARDING C M , NASR M A , KINSELLA R L , et al . Acinetobacter strains carry two functional oligosaccharyltransferases, one devoted exclusively to type Ⅳ pilin, and the other one dedicated to O -glycosylation of multiple proteins [J ] . Molecular Microbiology , 2015 , 96 ( 5 ): 1023 - 1041 .

HARDING C M , NASR M A , SCOTT N E , et al . A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host [J ] . Nature Communications , 2019 , 10 : 891 .

KNOOT C J , ROBINSON L S , HARDING C M . A minimal sequon sufficient for O -linked glycosylation by the versatile oligosaccharyltransferase PglS [J ] . Glycobiology , 2021 , 31 ( 9 ): 1192 - 1203 .

FELDMAN M F , MAYER BRIDWELL A E , SCOTT N E , et al . A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae [J ] . Proceedings of the National Academy of Sciences of the United States of America , 2019 , 116 ( 37 ): 18655 - 18663 .

DUKE J A , PASCHALL A V , ROBINSON L S , et al . Development and immunogenicity of a prototype multivalent group B Streptococcus bioconjugate vaccine [J ] . ACS Infectious Diseases , 2021 , 7 ( 11 ): 3111 - 3123 .

KNOOT C J , WANTUCH P L , ROBINSON L S , et al . Discovery and characterization of a new class of O -linking oligosaccharyltransferases from the Moraxellaceae family [J ] . Glycobiology , 2023 , 33 ( 1 ): 57 - 74 .

HARVEY H , KUS J V , TESSIER L , et al . Pseudomonas aeruginosa D-arabinofuranose biosynthetic pathway and its role in type Ⅳ pilus assembly [J ] . Journal of Biological Chemistry , 2011 , 286 ( 32 ): 28128 - 28137 .

HARDING C M , FELDMAN M F . Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli [J ] . Glycobiology , 2019 , 29 ( 7 ): 519 - 529 .

ZARSCHLER K , JANESCH B , PABST M , et al . Protein tyrosine O -glycosylation—a rather unexplored prokaryotic glycosylation system [J ] . Glycobiology , 2010 , 20 ( 6 ): 787 - 798 .

MAES E , KRZEWINSKI F , GARENAUX E , et al . Glycosylation of BclA glycoprotein from Bacillus cereus and Bacillus anthracis exosporium is domain-specific [J ] . Journal of Biological Chemistry , 2016 , 291 ( 18 ): 9666 - 9677 .

DEL BINO L , ØSTERLID K E , WU D Y , et al . Synthetic glycans to improve current glycoconjugate vaccines and fight antimicrobial resistance [J ] . Chemical Reviews , 2022 , 122 ( 20 ): 15672 - 15716 .

MICOLI F , COSTANTINO P , ADAMO R . Potential targets for next generation antimicrobial glycoconjugate vaccines [J ] . FEMS Microbiology Reviews , 2018 , 42 ( 3 ): 388 - 423 .

HUANG Y L , WU C Y . Carbohydrate-based vaccines: challenges and opportunities [J ] . Expert Review of Vaccines , 2010 , 9 ( 11 ): 1257 - 1274 .

WILDER-SMITH A . Meningococcal disease: risk for international travellers and vaccine strategies [J ] . Travel Medicine and Infectious Disease , 2008 , 6 ( 4 ): 182 - 186 .

Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP) [J/OL ] . MMWR Recommendations and Reports , 2000 , 49 (RR 07 ): 1 - 10 [ 2023-09-01 ] . https://www.cdc.gov/mmwr/preview/mmwrhtml/rr4907a1.htm https://www.cdc.gov/mmwr/preview/mmwrhtml/rr4907a1.htm .

SCHUERMAN L , PRYMULA R , HENCKAERTS I , et al . ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media [J ] . Vaccine , 2007 , 25 ( 11 ): 1962 - 1968 .

PRYMULA R , PEETERS P , CHROBOK V , et al . Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae : a randomised double-blind efficacy study [J ] . The Lancet , 2006 , 367 ( 9512 ): 740 - 748 .

ZHU H , ROLLIER C S , POLLARD A J . Recent advances in lipopolysaccharide-based glycoconjugate vaccines [J ] . Expert Review of Vaccines , 2021 , 20 ( 12 ): 1515 - 1538 .

COHEN D , ATSMON J , ARTAUD C , et al . Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study [J ] . The Lancet Infectious Diseases , 2021 , 21 ( 4 ): 546 - 558 .

FRENCK R W JR , ERVIN J , CHU L , et al . Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial [J ] . The Lancet Infectious Diseases , 2019 , 19 ( 6 ): 631 - 640 .

DAVID S , REUTER S , HARRIS S R , et al . Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread [J ] . Nature Microbiology , 2019 , 4 ( 11 ): 1919 - 1929 .

SHEN X , LAGERGÅRD T , YANG Y , et al . Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization [J ] . Infection and Immunity , 2001 , 69 ( 1 ): 297 - 306 .

DOW J M , MAURI M , SCOTT T A , et al . Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production [J ] . Expert Review of Vaccines , 2020 , 19 ( 6 ): 507 - 527 .

ROMANO M R , LEUZZI R , CAPPELLETTI E , et al . Recombinant Clostridium difficile toxin fragments as carrier protein for PSⅡ surface polysaccharide preserve their neutralizing activity [J ] . Toxins , 2014 , 6 ( 4 ): 1385 - 1396 .

NILO A , PASSALACQUA I , FABBRINI M , et al . Exploring the effect of conjugation site and chemistry on the immunogenicity of an anti-group B streptococcus glycoconjugate vaccine based on GBS67 pilus protein and type Ⅴ polysaccharide [J ] . Bioconjugate Chemistry , 2015 , 26 ( 8 ): 1839 - 1849 .

YUE H , MA G H . Polymeric micro/nanoparticles: particle design and potential vaccine delivery applications [J ] . Vaccine , 2015 , 33 ( 44 ): 5927 - 5936 .

NEEK M , KIM T I , WANG S W . Protein-based nanoparticles in cancer vaccine development [J ] . Nanomedicine: Nanotechnology, Biology, and Medicine , 2019 , 15 ( 1 ): 164 - 174 .

CHEN J Y , WANG P , YUAN L Z , et al . A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2 [J ] . Science Bulletin , 2022 , 67 ( 13 ): 1372 - 1387 .

CHARLTON HUME H K , VIDIGAL J , CARRONDO M J T , et al . Synthetic biology for bioengineering virus-like particle vaccines [J ] . Biotechnology and Bioengineering , 2019 , 116 ( 4 ): 919 - 935 .

LI X , PAN C , SUN P , et al . Orthogonal modular biosynthesis of nanoscale conjugate vaccines for vaccination against infection [J ] . Nano Research , 2022 , 15 ( 2 ): 1645 - 1653 .

PAN C , WU J , QING S , et al . Biosynthesis of self-assembled proteinaceous nanoparticles for vaccination [J ] . Advanced Materials , 2020 , 32 ( 42 ): e2002940 .

HUANG B , XU Y , HU X H , et al . A backbone-centred energy function of neural networks for protein design [J ] . Nature , 2022 , 602 ( 7897 ): 523 - 528 .

PENG Z H , WU J , WANG K F , et al . Production of a promising biosynthetic self-assembled nanoconjugate vaccine against Klebsiella pneumoniae serotype O 2 in a general Escherichia coli host [J ] . Advanced Science , 2021 , 8 ( 14 ): e2100549 .

SHI Y X , PAN C , WANG K F , et al . Construction of orthogonal modular proteinaceous nanovaccine delivery vectors based on mSA-biotin binding [J ] . Nanomaterials , 2022 , 12 ( 5 ): 734 .

TEMME K , ZHAO D H , VOIGT C A . Refactoring the nitrogen fixation gene cluster from Klebsiella oxytoca [J ] . Proceedings of the National Academy of Sciences of the United States of America , 2012 , 109 ( 18 ): 7085 - 7090 .

SMANSKI M J , BHATIA S , ZHAO D H , et al . Functional optimization of gene clusters by combinatorial design and assembly [J ] . Nature Biotechnology , 2014 , 32 ( 12 ): 1241 - 1249 .

ZELCBUCH L , ANTONOVSKY N , BAR-EVEN A , et al . Spanning high-dimensional expression space using ribosome-binding site combinatorics [J ] . Nucleic Acids Research , 2013 , 41 ( 9 ): e98 .

TAYLOR G M , MORDAKA P M , HEAP J T . Start-Stop Assembly: a functionally scarless DNA assembly system optimized for metabolic engineering [J ] . Nucleic Acids Research , 2019 , 47 ( 3 ): e17 .

KAY E J , MAURI M , WILLCOCKS S J , et al . Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines [J ] . Microbial Cell Factories , 2022 , 21 ( 1 ): 66 .

GASPERINI G , RASO M M , SCHIAVO F , et al . Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O -Antigens [J ] . NPJ Vaccines , 2022 , 7 : 69 .

JAROENTOMEECHAI T , KWON Y H , LIU Y W , et al . A universal glycoenzyme biosynthesis pipeline that enables efficient cell-free remodeling of glycans [J ] . Nature Communications , 2022 , 13 : 6325 .

GLASSCOCK C J , YATES L E , JAROENTOMEECHAI T , et al . A flow cytometric approach to engineering Escherichia coli for improved eukaryotic protein glycosylation [J ] . Metabolic Engineering , 2018 , 47 : 488 - 495 .

CERONI F , ALGAR R , STAN G B , et al . Quantifying cellular capacity identifies gene expression designs with reduced burden [J ] . Nature Methods , 2015 , 12 ( 5 ): 415 - 418 .

LINTON D , DORRELL N , HITCHEN P G , et al . Functional analysis of the Campylobacter jejuni N -linked protein glycosylation pathway [J ] . Molecular Microbiology , 2005 , 55 ( 6 ): 1695 - 1703 .

NEUHARD J , THOMASSEN E . Altered deoxyribonucleotide pools in P2 eductants of Escherichia coli K-12 due to deletion of the dcd gene [J ] . Journal of Bacteriology , 1976 , 126 ( 2 ): 999 - 1001 .

ALAIMO C , CATREIN I , MORF L , et al . Two distinct but interchangeable mechanisms for flipping of lipid-linked oligosaccharides [J ] . The EMBO Journal , 2006 , 25 ( 5 ): 967 - 976 .

PÉREZ J M , MCGARRY M A , MAROLDA C L , et al . Functional analysis of the large periplasmic loop of the Escherichia coli K-12 WaaL O -antigen ligase [J ] . Molecular Microbiology , 2008 , 70 ( 6 ): 1424 - 1440 .

MUSUMECI M A , FARIDMOAYER A , WATANABE Y , et al . Evaluating the role of conserved amino acids in bacterial O -oligosaccharyltransferases by in vivo , in vitro and limited proteolysis assays [J ] . Glycobiology , 2014 , 24 ( 1 ): 39 - 50 .

STRUTTON B , JAFFÉ S R P , PANDHAL J , et al . Producing a glycosylating Escherichia coli cell factory: the placement of the bacterial oligosaccharyl transferase pglB onto the genome [J ] . Biochemical and Biophysical Research Communications , 2018 , 495 ( 1 ): 686 - 692 .

YATES L E , NATARAJAN A , LI M J , et al . Glyco-recoded Escherichia coli : recombineering-based genome editing of native polysaccharide biosynthesis gene clusters [J ] . Metabolic Engineering , 2019 , 53 : 59 - 68 .

NATARAJAN A , JAROENTOMEECHAI T , LI M J , et al . Metabolic engineering of glycoprotein biosynthesis in bacteria [J ] . Emerging Topics in Life Sciences , 2018 , 2 ( 3 ): 419 - 432 .

YU H , CHEN X . One-pot multienzyme (OPME) systems for chemoenzymatic synthesis of carbohydrates [J ] . Organic & Biomolecular Chemistry , 2016 , 14 ( 10 ): 2809 - 2818 .

GUARINO C , DELISA M P . A prokaryote-based cell-free translation system that efficiently synthesizes glycoproteins [J ] . Glycobiology , 2012 , 22 ( 5 ): 596 - 601 .

SHIMIZU Y , INOUE A , TOMARI Y , et al . Cell-free translation reconstituted with purified components [J ] . Nature Biotechnology , 2001 , 19 ( 8 ): 751 - 755 .

STARK J C , JAROENTOMEECHAI T , MOELLER T D , et al . On-demand, cell-free biomanufacturing of conjugate vaccines at the point-of-care [EB/OL ] . bioRxiv , 2019 : 681841 [ 2023-09-01 ] . https://www.biorxiv.org/content/10.1101/681841v1 https://www.biorxiv.org/content/10.1101/681841v1 .

NATARAJAN A , JAROENTOMEECHAI T , CABRERA-SÁNCHEZ M , et al . Engineering orthogonal human O -linked glycoprotein biosynthesis in bacteria [J ] . Nature Chemical Biology , 2020 , 16 ( 10 ): 1062 - 1070 .